Showing results (101-110 of 538) with videos related to

Sort By:
Pageof 54
Expert Review of Anticancer Therapy|June 21, 2019
Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncologyGabriele Di Sante, Jessica Pagé, Xuanmao Jiao, et al.
Breast Cancer Research and Treatment|October 2, 2015
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groupsKatharine Yao, Robert Goldschmidt, Mary Turk, et al.
The Breast Journal|December 21, 2012
Acceptability and adherence in a chemoprevention trial among women at increased risk for breast cancer attending the Modena Familial Breast and Ovarian Cancer Center (Italy)Elisabetta Razzaboni, Angela Toss, Laura Cortesi, et al.
Cancers|June 22, 2023
ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast CancerDong Li, Hami Hemati, Younhee Park, et al.
Cellular Signalling|February 22, 2020
Regulation of KLF4 by posttranslational modification circuitry in endocrine resistanceZhuan Zhou, Xinxin Song, Junlong Jack Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studiesGiandomenico Roviello, Fabrice Andre, Sergio Venturini, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 10, 2020
The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, studyGiovanni Grandi, Maria Chiara Del Savio, Margaret Sammarini, et al.
Endocrine-Related Cancer|March 27, 2023
Talking about sex: erectile dysfunction in the oncology patientMarilina Romeo, Giorgia Spaggiari, Chiara Furini, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2007
Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivoRadka Stoyanova, Paul Hachem, Harvey Hensley, et al.
International Journal of Molecular Sciences|July 9, 2022
Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast CancerKirby P Gardner, Massimo Cristofanilli, Saranya Chumsri, et al.
Pageof 54